PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.10) per share. The company reported quarterly sales of $65.317 million which beat the analyst consensus estimate of $65.000 million by 0.49 percent. This is a 10.95 percent increase over sales of $58.870 million the same period last year.
PetMed Express Q3 2024 GAAP EPS $(0.10), Sales $65.317M Beat $65.000M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.